personalized medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
personalized medicine
Apr 16, 2024, 12:53 |
Positive
A few reasons why we feel honored to work alongside this champion for accessible cancer treatment - The Max Foundation
The Max Foundation shared on LinkedIn: “On this Good Deeds Day, we're highlighting the remarkable…
Mar 20, 2024, 16:25 |
Opinion
Douglas Flora: CHAT-GPT now has a body
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post…
Mar 7, 2024, 17:47 |
Blog
Janice Cowden: As people diagnosed with metastatic breast cancer, we have a lot to say about dose optimization and treatment-related side effects
Janice Cowden shared a post on LinkedIn: "As people diagnosed with metastatic breast cancer, we…
Mar 6, 2024, 09:42 |
Blog
Wafik El-Deiry: The founders of the WIN Consortium had a bold vision for global impact in personalized cancer medicine
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Dec 31, 2023, 19:46 |
Insight
Marko Gangur: The Manifesto for the European Parliament elections 2024
Marko Gangur, HPV Action Consultant for Croatia at European Cancer Organisation, shared on LinkedIn: "The…
Dec 17, 2023, 01:14 |
Blog
Matteo G Della Porta: Humanitas is making waves at ASH2023!
Matteo G Della Porta, Full Professor of Hematology - Humanitas University & Head, Leukemia Unit…
1
2
All:
16
Posts:
11 - 20
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Facebook
RSS Feed
Twitter
Linkedin
Youtube